$DNA
Ginkgo Bioworks Holdings, Inc.
CIK:0001830214|SEC Filings
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|||
| Income Statement [Abstract] | ||||||
| Revenue | [1] | $ 20,156 | $ 39,134 | $ 39,630 | $ 77,364 | |
| Costs and operating expenses: | ||||||
| Cost of other revenue | 1,719 | 5,380 | 4,817 | 9,470 | ||
| Research and development | 46,210 | 53,370 | 96,130 | 124,293 | ||
| General and administrative | 30,775 | 34,981 | 68,605 | 74,704 | ||
| Restructuring charges | 0 | 3,566 | 0 | 8,032 | ||
| Total operating expenses | 78,704 | 97,297 | 169,552 | 216,499 | ||
| Loss from operations | (58,548) | (58,163) | (129,922) | (139,135) | ||
| Other income (expense): | ||||||
| Interest income, net | 3,232 | 6,083 | 6,828 | 12,164 | ||
| Loss on equity method investment | (4,673) | 0 | (4,673) | 0 | ||
| Gain (loss) on investments | 1,987 | (229) | 773 | (3,922) | ||
| Other income (expense), net | 809 | (1,168) | (6,338) | (5,806) | ||
| Total other income (expense) | 1,355 | 4,686 | (3,410) | 2,436 | ||
| Loss from continuing operations before income taxes | (57,193) | (53,477) | (133,332) | (136,699) | ||
| Income tax (benefit) expense | 128 | (283) | 48 | (195) | ||
| Net loss from continuing operations | (57,321) | (53,194) | (133,380) | (136,504) | ||
| Net income (loss) from discontinued operations, net of tax | 10,611 | (7,106) | 4,083 | (14,753) | ||
| Net loss | $ (46,710) | $ (60,300) | $ (129,297) | $ (151,257) | ||
| Basic from continuing operations (in dollars per share) | $ (0.92) | $ (0.97) | $ (2.19) | $ (2.50) | ||
| Basic from discontinued operations (in dollars per share) | 0.17 | (0.13) | 0.06 | (0.27) | ||
| Net loss per share, basic (in dollars per share) | $ (0.75) | $ (1.10) | $ (2.13) | $ (2.77) | ||
| Weighted average common shares outstanding: | ||||||
| Basic (in shares) | 62,094,356 | 54,858,982 | 60,835,896 | 54,552,006 | ||
| Net loss | $ (46,710) | $ (60,300) | $ (129,297) | $ (151,257) | ||
| Other comprehensive (loss) income: | ||||||
| Foreign currency translation adjustment | (34) | 2,586 | (613) | 3,435 | ||
| Unrealized (loss) gain on available-for-sale securities | (210) | (83) | (288) | 24 | ||
| Total other comprehensive (loss) income | (244) | 2,503 | (901) | 3,459 | ||
| Comprehensive loss | $ (46,954) | $ (57,797) | $ (130,198) | $ (147,798) | ||
| ||||||